However, a study specifically looking at MLL-AF4+ infant B-ALL showed that exclusively the more mature CD34+CD19+ and CD34-CD19+ B-ALL cell populations could engraft[155]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.